Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. (MGTA) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 95 transactions totaling $17.6M, demonstrating a bullish sentiment with $2.6M in net insider flow. The most recent transaction on Feb 8, 2023 involved a sale of 1,500,000 shares valued at $1.2M.
MGTA Insider Activity Summary
Who Is Buying MGTA Stock?
No significant insider buying has been recorded for MGTA in the recent period.
Who Is Selling MGTA Stock?
No significant insider selling has been recorded for MGTA in the recent period.
Is Magenta Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MGTA is bullish with an Insider Alignment Score of 58/100 and a net flow of $2.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MGTA Frequently Asked Questions
Understanding MGTA Insider Activity
Insider trading at Magenta Therapeutics, Inc. (MGTA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading MGTA stock, having executed 95 transactions in the past 90 days. The most active insider is Bruce Booth (Executive), who has made 5 transactions totaling $10.3M.
Related Tools
Track Magenta Therapeutics, Inc. Insider Activity
Get notified when executives and directors at MGTA file new Form 4 transactions